Below we list the current VCT offers available for investment. Each is accompanied by a brief commentary. For each of our Featured Offers we also provide an extended research note.
VCTs are riskier than conventional investments so they're not for everyone. Before you invest you should ensure you have read and understood the product's Application Pack and the Risks and Commitments.
Pembroke's manager, Oakley Capital, is a long established name in venture capital investing. This VCT is one of the few investing in growth-orientated companies: as such the recent rule changes on MBOs have little or no impact on them. Investments are focused on scalable consumer brands; ones which investors can walk down the high street and see. This VCT is worthy of consideration.
New, evergreen share class – growth-focused but with a preference for asset-backed businesses, a particular specialism of Downing, which may offer some downside protection. Unusual zero-discount buyback policy. For investors who don’t mind foregoing dividend income for the first few years, this may be an offer to consider.
This new share class for the longstanding Downing Four VCT is looking to raise £10 million (with a further over-allotment of £10m) to invest in early-stage healthcare, biotechnology and life sciences businesses. Downing is the overall manager, but will use the skills of specialist healthcare investor BioScience Managers to source and manage deals.
Generalist VCT with a focus on growth businesses, particularly in software and computer services. Now co-invests alongside Draper Esprit which should enhance deal flow and opportunities to invest in larger more established businesses.
Downing FOUR VCT plc is creating two new share classes for subscription in the 2016/17 tax year – Generalist, and Healthcare.Downing FOUR was created in 2015 by merging four other VCTs that were managed or advised ...
This £70 million offer is a top up to the UK's largest VCT, Octopus Titan, which currently has assets of approximately £309 million. This long-standing VCT was first launched in 2007 and has around 60 companies ...
This is a top up to the longstanding Foresight VCT, raising £20 million with an over-allotment of £20 million. This is is a generalist evergreen VCT. Assuming full subscription this VCT will have assets of approximately ...
This is a top-up offer to the longstanding Octopus AIM VCT and Octopus AIM VCT 2. Combined they have over £158 million of assets; the first VCT has 71 holdings and the second has 69. Investors ...
This website is directed exclusively at, and intended to be used only by, persons in the UK who will be required to self-certify as Sophisticated Investors or High Net Worth Individuals before applying to invest in any of the products featured. It is not directed at any person where (by reason of nationality, residence, domicile or otherwise) the usage of the website is prohibited.
The investment products on this website are not for everyone. They are generally higher risk and require a longer investment term. You may get back less than you invest. It is therefore important that you understand the Risks and Commitments of these products.
We’ve made every effort to ensure the accuracy of the material on this website, but cannot guarantee its accuracy or currency. It reflects our understanding of current product and tax rules, which may change in future. It is for general information only and should not be regarded as constituting an offer or a solicitation to buy or sell any securities, or as investment or tax advice. If you are in any doubt as to the suitability of the products for your circumstances, please seek specialist financial or tax advice.
Wealth Club Limited is not responsible for the content of external third party material featured on our website.